The Board of Directors of the company in its meeting held today on July 31, 2025 have taken note of resignation of Mr. Devanshu Ravinder Dange (A76053) from the position of Company Secretary, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Hindustan Bio Sciences Ltd met on July 31, 2025 and approved the unaudited standalone financial results for Q1 FY26 (ended June 30, 2025). Revenue from operations stood at Rs 32.19 lakhs, down from Rs 41.11 lakhs in Q1 FY25, while profit for the quarter was just Rs 1.40 lakhs (vs Rs 8.18 lakhs YoY). The Board also noted the resignation of Mr. Devanshu Ravinder Dange as Company Secretary, Compliance Officer and Key Managerial Personnel, effective end of July 31, 2025, citing personal reasons. Mr. Shailendra Vyas (ICSI member) has been appointed in his place effective August 1, 2025. The notice for the 33rd Annual General Meeting was approved, and the Secretarial Audit Report for FY25 was adopted.
Routine KMP transition with no governance red flags — the outgoing Company Secretary explicitly confirmed no material reason beyond personal reasons. However, the financials are weak: revenues are declining YoY, profits have shrunk sharply, and reserves remain negative at Rs (114.52) lakhs, signalling ongoing stress on the business. Limited impact expected on stock price from the KMP change alone.